Protect and Inform
“Most of the pharma companies are trying to find ways to grow, so they’re trying to focus on emerging markets, which could mean developing nations and the BRIC (Brazil, Russia, India, China) countries,” Dixon explains. “What that means to us is more languages and more SKUs for shipping to different countries and also dealing with different regulatory bodies.”
Strategic Growth
Dixon says Rondo-Pak’s Pennsylvania facility is a modest location that has been optimized for the amount of volume that flows through it. Still, the company continues to grow at rates of more than 20 percent each year, which goes back to the integration Rondo-Pak has with its sister companies.
As the company continues to grow, Dixon says that he’s mulling whether to move to a new local facility or expand on the current location. But, he explains, as long as the cartons are high quality and innovative and the five sister companies maximize their integration, Rondo’s growth should continue.
Within the entire corporate group, he explains, the goal is to provide a complete end-to-end solution, from the packaging lines to the packages themselves, including the necessary software and inspection systems needed along the way.
“Our growth has been phenomenal, which is a great problem to have,” he says. “We’re looking for ways to continue to see our growth unencumbered.”
Cory Francer is an analyst at NAPCO Research. He formerly served as editor-in-chief of Packaging Impressions.